Are you looking for a growth opportunity? I might have it here for you. We are representing a small publicly traded company which likes you to have a hands on approach to developing programs and overall Infrastructure. This includes a private; public; cloud along with vendors and partner expertise! My client wants to move everything
Some-days, I believe I could be a diamond stonecutter. Specifically, when it comes to studying which angle must be struck to reveal the most brilliance of the diamond. We have been referred to what we consider a Gem of a Physician and businessperson. He is American Board Certified in Internal Medicine and American Board
CytRx, a biopharmaceutical research and development company specializing in oncology, announced encouraging overall survival (OS) results, the secondary endpoint, from its completed multicenter, randomized, open-label global Phase 2b clinical trial investigating the efficacy and safety of aldoxorubicin compared with doxorubicin as first-line therapy in subjects with metastatic, locally advanced or unresectable soft tissue sarcomas (STS).